Jezequel A M, Librari M L, Mosca P, Novelli G, Lorenzini I, Orlandi F
Liver. 1984 Oct;4(5):307-17. doi: 10.1111/j.1600-0676.1984.tb00943.x.
The study reports functional and morphological findings in eight male subjects undergoing anticonvulsant therapy for periods from 20 days up to 15 years. All subjects showed an increased activity of the hepatic microsomal NADPH cytochrome c reductase and an increased amount of smooth membranes in hepatocytes. The enzymatic activity was higher in the first years of treatment. Quantitative ultrastructural analysis showed that a twofold increase of the smooth membranes of hepatocytes had already been reached after 20 days of therapy, with a modest additional increase occurring thereafter. Both enzymatic and structural changes appear to be related to therapy. In addition, abnormal lipofuscin-related cytoplasmic formations were present in the hepatocytes of five subjects. Such formations are thought to represent an accumulation of abnormal degradation products, possibly related to an interaction of the drug(s) metabolites with cellular components.
该研究报告了8名接受抗惊厥治疗20天至15年的男性受试者的功能和形态学研究结果。所有受试者均表现出肝微粒体NADPH细胞色素c还原酶活性增加,肝细胞中光滑膜数量增多。酶活性在治疗的最初几年较高。定量超微结构分析表明,治疗20天后肝细胞光滑膜已增加两倍,此后有适度的额外增加。酶学和结构变化似乎均与治疗有关。此外,5名受试者的肝细胞中存在与脂褐素相关的异常细胞质结构。这种结构被认为代表异常降解产物的积累,可能与药物代谢产物与细胞成分的相互作用有关。